SCHEMBL10604202

SCHEMBL10604202

CCCCOc1ccc(OC)c2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.54
CNR2 P34972 3/20 0.54
CYP2C9 P11712 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C19 P33261 1/20 0.52
TDP1 Q9NUW8 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
GAA P10253 1/20 0.51
SLC2A1 P11166 3/20 0.50
IDO1 P14902 1/20 0.50
GPR84 Q9NQS5 1/20 0.50
EP300 Q09472 1/20 0.48
KAT8 Q9H7Z6 1/20 0.48
MEN1 O00255 1/20 0.48
HTT P42858 1/20 0.48
KMT2A Q03164 1/20 0.48
HTR1B P28222 2/20 0.47
IMPDH2 P12268 1/20 0.46
IMPDH1 P20839 1/20 0.46
THRA P10827 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12968475 0.92 SMN1; SMN2 (0.52) CNR1CNR2CYP2C9CYP1A2CYP2C19
SCHEMBL29502701 0.92 CNR1 (0.59) CNR1CNR2CYP2C9CYP1A2CYP2C19
SCHEMBL9770405 0.92 CNR1 (0.59) CNR1CNR2CYP2C9CYP1A2CYP2C19
SCHEMBL10605542 0.90 CNR1 (0.53) CNR1CNR2CYP2C9SLC2A1IDO1
SCHEMBL10605887 0.88 CNR1 (0.56) CNR1CNR2CYP2C9CYP1A2CYP2C19
SCHEMBL10602032 0.86 CNR2 (0.55) CNR1CNR2CYP2C9CYP1A2CYP2C19
SCHEMBL29428922 0.86 CNR1 (0.55) CNR1CNR2CYP2C9CYP1A2CYP2C19
SCHEMBL29802552 0.86 CNR1 (0.60) CNR1CNR2CYP2C9CYP1A2CYP2C19
SCHEMBL23271677 0.84 CNR1 (0.61) CNR1CNR2CYP2C9CYP1A2CYP2C19
SCHEMBL19612290 0.84 CNR1 (0.61) CNR1CNR2CYP2C9CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116360211-A Chemically amplified positive photosensitive resin composition, protective film, and element having protective film 奇美实业股份有限公司 2023-06-30 CN disclosed
US-11613509-B2 Radical polymerization control agent and radical polymerization control method KAWASAKI KASEI CHEMICALS LTD. (JP) 2023-03-28 US disclosed
CN-110891980-B Radical polymerization control agent and radical polymerization control method 川崎化成工业株式会社 2022-09-30 CN disclosed
US-20210122692-A1 RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD KAWASAKI KASEI CHEMICALS LTD. (JP) 2021-04-29 US disclosed
CN-110891980-A Radical polymerization control agent and radical polymerization control method 川崎化成工业株式会社 2020-03-17 CN disclosed
US-9067934-B2 Bicyclic pyridinones PFIZER INC. (US) 2015-06-30 US disclosed
US-20140045790-A1 Novel Bicyclic Pyridinones PFIZER INC. (US) 2014-02-13 US disclosed
US-20120252758-A1 Novel Bicyclic Pyridinones PFIZER INC. 2012-10-04 US disclosed
EP-0189760-B1 THERMOSENSITIVE RECORDING SHEET JUJO PAPER CO., LTD. (JP) 1989-07-19 EP disclosed
US-4721701-A Thermosensitive recording sheet JUJO PAPER CO., LTD. (JP) 1988-01-26 US disclosed
EP-0189760-A1 Thermosensitive recording sheet JUJO PAPER CO., LTD. (JP) 1986-08-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11613509-B2 Radical polymerization control agent and radical polymerization control method PPOX, NOX4, CROCC CNR1 2468/4885CNR2 2311/4885CYP2C9 568/4885
US-20210122692-A1 RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD PPOX, NOX4, CROCC CNR1 2468/4885CNR2 2311/4885CYP2C9 568/4885
US-20140045790-A1 Novel Bicyclic Pyridinones CYP2B6, CYP2C19, CYP2D6 CNR1 239/4885CNR2 303/4885CYP2C9 17/4885
US-20120252758-A1 Novel Bicyclic Pyridinones CYP2B6, CYP2C19, CYP2D6 CNR1 239/4885CNR2 303/4885CYP2C9 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.